C. Tsai

HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in Taiwan.

S. Sullivan, M. Lai, D. Veenstra, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost‐effectiveness of peginterferon alfa‐2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

S. Sullivan, D. Veenstra, Ting Chang, 2007, Journal of gastroenterology and hepatology.